Either loss of AICDA or DNMT1 with the instability of the AICDA-DNMT1 complex on the BCL6 promoter result in BCL6 promoter demethylation leading to increased BCL6 expression in DLBCL [28]. The gene discussed is DNMT1; the disease is diffuse large B-cell lymphoma.